17 Results for "

Fabp5

" in MedChemExpress (MCE) Product Catalog:
Products (17)

17 Results for "Fabp5" in MCE Product Catalog:

  • Targets Recommended:
29
29 Publications Verification
Cat. No.: HY-101903
CAS No.: 300657-03-8
Purity:  99.93%
Target:  

FABP

BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .
loading...
    loading...
29
29 Publications Verification
Cat. No.: HY-101903A
CAS No.: 2802523-05-1
Purity:  99.93%
Target:  

FABP

BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 sodium improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-145990
CAS No.: 2988135-14-2
Purity:  99.86%
Synonyms: MF6
Target:  

FABP

Research Areas:  

Inflammation/Immunology

FABPs ligand 6 (MF6) is an FABP5 and FABP7 inhibitor with KD values of 874 nM and 20 nM, respectively. FABPs ligand 6 can be used for multiple sclerosis research .
loading...
    loading...
Cat. No.: HY-161702
CAS No.: 1433901-75-7
Target:  

FABP

Research Areas:  

Inflammation/Immunology

RO6806051 is a selectivity FABP4 and FABP5 inhibitor with human FABP4 Ki values of 0.011 μM and 0.23 μM, and human FABP5 Ki values of 0.086 μM and 1.17 μM. RO6806051 can be used for the research of inflammation-related diseases .
loading...
    loading...
Cat. No.: HY-RS04661
Research Areas:  

Others

FABP5 Human Pre-designed siRNA Set A contains three designed siRNAs for FABP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-160457
CAS No.: 2862791-11-3
Target:  

FABP

Research Areas:  

Metabolic Disease

FABP4/5-IN-5 (compound D9) is a potent inhibitor of FABP4 and FABP5,? with the IC50s of 4.68 μM and 10.72 μM, respectively.FABP4/5-IN-5 plays an important role in metabolism disorder like diabetes mellitus .
loading...
    loading...
Cat. No.: HY-N8144
CAS No.: 95262-48-9
Niga-ichigoside F1, an orally active ursane triterpenoid, has antihyperlipidemic and antioxidant activities. Niga-ichigoside F1 can prevent high-fat diet (HFD)-induced hepatic steatosis .
loading...
    loading...
Cat. No.: HY-RS16605
Research Areas:  

Others

Fabp5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Fabp5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23039
Research Areas:  

Others

Fabp5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Fabp5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-160456
CAS No.: 2862795-48-8
Target:  

FABP

Research Areas:  

Metabolic Disease

FABP4/5-IN-4 (compound E1) is a potent inhibitor of FABP4 and FABP5, with the IC50s of 3.78 μM and 5.72 μM, respectively. FABP4/5-IN-4 plays an important role in metabolism disorder like diabetes mellitus .
loading...
    loading...
Cat. No.: HY-P75214
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Fatty acid-binding protein 5; E-Fabp; PA-Fabp; Fabp5
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P72660
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Fatty acid-binding protein 5; E-Fabp; PA-Fabp; Fabp5
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-101903AR
CAS No.: 2802523-05-1
BMS-309403 (sodium) (Standard) is the analytical standard of BMS-309403 (sodium). This product is intended for research and analytical applications. BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 sodium improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .
loading...
    loading...
Cat. No.: HY-101903R
CAS No.: 300657-03-8
BMS-309403 (Standard) is the analytical standard of BMS-309403. This product is intended for research and analytical applications. BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .
loading...
    loading...
Cat. No.: HY-183836
CAS No.: 1227413-92-4
Target:  

FABP

Research Areas:  

Cardiovascular Disease

FABP4/5-IN-7 is a dual FABP4/FABP5 inhibitor, with an IC50 of 0.8 μM and a Kd of 0.01 μM for FABP4, and an IC50 of 1.4 μM for FABP5. FABP4/5-IN-7 inhibits lipolysis in adipocytes. FABP4/5-IN-7 inhibits MCP-1 release in macrophages. FABP4/5-IN-7 improves dyslipidemia in diet-induced obese mice. FABP4/5-IN-7 can be used in studies related to dyslipidemia .
loading...
    loading...
Cat. No.: HY-P79398
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Fatty acid-binding protein 5; Fabp5; Epidermal-type fatty acid-binding protein; E-Fabp; Fatty acid-binding protein, epidermal; Keratinocyte lipid-binding protein; Psoriasis-associated fatty acid-binding protein homolog; PA-Fabp; Fabpe; Klbp; Mal1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-178471
CAS No.: 2975215-64-4
FABP4/5-IN-6 is an orally active, potent FABP4/5 inhibitor (Ki = 0.41/2.53 μM), showing low selectivity over FABP3 (Ki = 59.72 μM). FABP4/5-IN-6 inhibits the secretion of MCP-1 and IL-6 in Lipopolysaccharides (HY-D1056) (LPS)-induced THP-1 macrophage. FABP4/5-IN-6 exhibits significant anti-inflammatory effects and attenuates LPS-induced liver injury. FABP4/5-IN-6 has low hERG inhibition (LD50 > 2000 mg/kg). FABP4/5-IN-6 can be used for the study of Inflammation-related diseases .
loading...
    loading...
  • 1